- Home
- BLIV vs ANTX Comparison
BLIV vs ANTX Comparison
Compare BLIV & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLIV
- ANTX
- Stock Information
- Founded
- BLIV 2014
- ANTX 2017
- Country
- BLIV Singapore
- ANTX United States
- Employees
- BLIV N/A
- ANTX N/A
- Industry
- BLIV
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- BLIV
- ANTX Health Care
- Exchange
- BLIV NYSE
- ANTX Nasdaq
- Market Cap
- BLIV 39.8M
- ANTX 41.2M
- IPO Year
- BLIV 2025
- ANTX 2022
- Fundamental
- Price
- BLIV $3.04
- ANTX $1.26
- Analyst Decision
- BLIV
- ANTX Buy
- Analyst Count
- BLIV 0
- ANTX 4
- Target Price
- BLIV N/A
- ANTX $3.50
- AVG Volume (30 Days)
- BLIV 736.0K
- ANTX 79.8K
- Earning Date
- BLIV 01-01-0001
- ANTX 05-13-2025
- Dividend Yield
- BLIV N/A
- ANTX N/A
- EPS Growth
- BLIV N/A
- ANTX N/A
- EPS
- BLIV N/A
- ANTX N/A
- Revenue
- BLIV $1,915,838.00
- ANTX N/A
- Revenue This Year
- BLIV N/A
- ANTX N/A
- Revenue Next Year
- BLIV N/A
- ANTX N/A
- P/E Ratio
- BLIV N/A
- ANTX N/A
- Revenue Growth
- BLIV N/A
- ANTX N/A
- 52 Week Low
- BLIV $2.80
- ANTX $0.87
- 52 Week High
- BLIV $6.40
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- BLIV N/A
- ANTX 44.61
- Support Level
- BLIV N/A
- ANTX $1.18
- Resistance Level
- BLIV N/A
- ANTX $1.33
- Average True Range (ATR)
- BLIV 0.00
- ANTX 0.09
- MACD
- BLIV 0.00
- ANTX -0.01
- Stochastic Oscillator
- BLIV 0.00
- ANTX 42.86
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.